Wee1 Antibodies
Target Information
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. WEE1 subfamily. 2 alternatively spliced human isoforms have been reported. Note: This description may include information from UniProtKB.
Alternate Names
DKFZp686I18166; FLJ16446; WEE1; WEE1 G2 checkpoint kinase; WEE1 homolog; Wee1-like protein kinase; WEE1+ homolog; WEE1A; Wee1A kinase; WEE1huWee1 Antibody Products
16 Products- 53692WBIHCFH, M, R, MkRecombinant Monoclonal
- 98697H, M, R, MkRecombinant Monoclonal
- 15601H, M, R, MkRecombinant Monoclonal
- 26519H, M, R, MkRecombinant Monoclonal
- 36582H, M, R, MkRecombinant Monoclonal
- 48850H, M, R, MkRecombinant Monoclonal
- 65849H, M, R, MkRecombinant Monoclonal
- 74573H, M, R, MkRecombinant Monoclonal
- 72336H, M, R, MkRecombinant Monoclonal
- 87502H, M, R, MkRecombinant Monoclonal
- 98881H, M, R, MkRecombinant Monoclonal
- 93410H, M, R, MkRecombinant Monoclonal
Why CST
Cell Signaling Technology is trusted by the global scientific research community. Our highly cited antibodies offer unrivaled specificity and reproducibility. Learn more about why researchers choose CST:
Contact
Don’t see an antibody for your specific needs? Browse more products, learn more about our services or get in touch with us: